Allopurinol Dose Escalation for Gout Doesn ' t Improve Mortality

THURSDAY, Sept. 20, 2018 -- Allopurinol dose escalation is not associated with reductions in mortality risk among patients with gout, according to a study published in the August issue of Arthritis& Rheumatology. Brian W. Coburn, Ph.D., from...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news